Interferon alpha-2b biosimilar (Amoytop Biotech/BioGeneric Pharma)

干扰素α-2b生物类似药 (Amoytop Biotech/BioGeneric Pharma)

Report date: 2022/01/24 13:25:19

Base Information

Drug NameInterferon alpha-2b biosimilar (Amoytop Biotech/BioGeneric Pharma)
Drug Alias Name干扰素α-2b生物仿制药 (Amoytop Biotech/BioGeneric Pharma)rhIFNα-2b
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaPending
Originator CompaniesXiamen Amoytop Biotech Co LtdBiogeneric Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiogeneric PharmaXiamen Amoytop Biotech Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A